News
White & Case secures $405M jury win for Regeneron in antitrust case, with Amgen found liable for anti-competitive bundling ...
A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 million for ...
Biotech company Regeneron (NASDAQ:REGN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.7% year ...
At the J.P. Morgan Healthcare Conference in January, Regeneron CEO Leonard Schleifer said that the company’s new formulation of eye disease treatment Eylea needed “a few more arrows in its ...
Federal court jury found Amgen liable for violating antitrust and tort laws by using cross-therapeutic bundled rebates to prevent Praluent® (alirocumab) from competing in the market Jury awarded ...
Regeneron's first-quarter results missed Wall Street estimates on Tuesday due to stiff competition for its blockbuster drug ...
Regeneron argued that Amgen's tactics not ... tactics to push competitors out of the market," said Leonard S. Schleifer, M.D., Ph.D., Board co-Chair, President and Chief Executive Officer of ...
After consecutive setbacks at the FDA, Regeneron's string of recent troubles with its Eylea franchise is continuing to pull down the drugmaker. Over the first three months of 2025, Regeneron's ...
Regeneron paid roughly $500 per share in the $5 billion Sanofi share repurchase, which now appears quite positive relative to our valuation. Founder Leonard Schleifer has led Regeneron as chief ...
“Regeneron is an American success story ... invented in our New York laboratories,” President and CEO Leonard Schleifer said in a statement. “Our innovative approach has filled our ...
Leonard Schleifer; Co-Chairman of the Board, President, Chief Executive Officer, Founder; Regeneron Pharmaceuticals Inc George Yancopoulos; Co-Chairman of the Board, President, Chief Scientific ...
"Larger companies should not be allowed to use anticompetitive tactics to push competitors out of the market," Regeneron CEO Leonard Schleifer said in a statement. Tarrytown, N.Y.-based Regeneron ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results